Our finding in SLE–CMD that TIGIT levels are decreased suggests that there is a less exhausted phenotype in our cohort of SLE–CMD compared to SLE-non-CMD patients and indicates that T cell activity may contribute to microvascular dysfunction in CMD. This evidence concerns the gene TIGIT and systemic lupus erythematosus.